Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Vericel Corporation - Common Stock (NQ:VCEL)

43.14 -0.03 (-0.07%)
Streaming Delayed Price Updated: 9:44 AM EDT, Jun 5, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 9,494
Open 43.56
Bid (Size) 42.98 (2)
Ask (Size) 43.30 (1)
Prev. Close 43.17
Today's Range 42.54 - 43.77
52wk Range 37.39 - 63.00
Shares Outstanding 46,631,158
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
What Analysts Are Saying About Vericel Stock
Via Benzinga
VERICEL CORP (NASDAQ:VCEL) – A Strong Growth Stock with a Technical Setup
VERICEL CORP (NASDAQ:VCEL) shows strong growth potential with solid profitability and a promising technical setup, making it a stock worth watching. 
Via Chartmill

Performance

YTD
-21.7%
-21.7%
1 Month
+11.4%
+11.4%
3 Month
-17.6%
-17.6%
6 Month
-26.4%
-26.4%
1 Year
-10.1%
-10.1%

More News

Read More
Vericel Reports First Quarter 2025 Financial Results and Raises Full-Year Profitability Guidance
From Vericel Corporation
Via GlobeNewswire
Earnings Scheduled For May 8, 2025
Via Benzinga
Vericel to Present at the Bank of America Securities 2025 Healthcare Conference on Wednesday, May 14, 2025
From Vericel Corporation
Via GlobeNewswire
Where Vericel Stands With Analysts
Via Benzinga
Earnings Scheduled For February 27, 2025
Via Benzinga
What 7 Analyst Ratings Have To Say About Vericel
Via Benzinga
Beyond The Numbers: 5 Analysts Discuss Vericel Stock
Via Benzinga
Vericel to Report First-Quarter 2025 Financial Results on May 8, 2025
From Vericel Corporation
Via GlobeNewswire
Vericel to Present at Multiple Upcoming Investor Conferences
From Vericel Corporation
Via GlobeNewswire
Vericel Reports Fourth Quarter and Full-Year 2024 Financial Results
From Vericel Corporation
Via GlobeNewswire
Vericel to Report Fourth-Quarter and Full-Year 2024 Financial Results on February 27, 2025
From Vericel Corporation
Via GlobeNewswire
Earnings Preview For Vericel
Via Benzinga
The Analyst Verdict: Vericel In The Eyes Of 7 Experts
Via Benzinga
Applied Digital, Vericel, Calavo Growers And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Via Benzinga
Vericel Announces Preliminary 2024 Financial Results, 2025 Financial Guidance and Increased Mid-Term Profitability Targets
From Vericel Corporation
Via GlobeNewswire
Vericel to Present at the 43rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2025
From Vericel Corporation
Via GlobeNewswire
Vericel Stock Sees RS Rating Shoot Higher
Via Investor's Business Daily
Smaller Cap Biotechs Are In Season: How Are We Doing?
Via Talk Markets
Vericel Reports Third Quarter 2024 Financial Results
From Vericel Corporation
Via GlobeNewswire
Vericel to Report Third-Quarter 2024 Financial Results on November 7, 2024
From Vericel Corporation
Via GlobeNewswire
Vericel to Present at the Morgan Stanley Global Healthcare Conference on Friday, September 6, 2024
From Vericel Corporation
Via GlobeNewswire
Vericel Announces FDA Approval and Commercial Availability of MACI Arthro
From Vericel Corporation
Via GlobeNewswire
Vericel Announces FDA Approval of NexoBrid for the Treatment of Pediatric Patients with Severe Thermal Burns
From Vericel Corporation
Via GlobeNewswire

Frequently Asked Questions

Is Vericel Corporation - Common Stock publicly traded?
Yes, Vericel Corporation - Common Stock is publicly traded.
What exchange does Vericel Corporation - Common Stock trade on?
Vericel Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Vericel Corporation - Common Stock?
The ticker symbol for Vericel Corporation - Common Stock is VCEL on the Nasdaq Stock Market
What is the current price of Vericel Corporation - Common Stock?
The current price of Vericel Corporation - Common Stock is 43.14
When was Vericel Corporation - Common Stock last traded?
The last trade of Vericel Corporation - Common Stock was at 06/05/25 09:44 AM ET
What is the market capitalization of Vericel Corporation - Common Stock?
The market capitalization of Vericel Corporation - Common Stock is 2.01B
How many shares of Vericel Corporation - Common Stock are outstanding?
Vericel Corporation - Common Stock has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.